Zimmer Biomet Holdings Inc. ($ZBH) Stock Forecast: Down 10.1% Today

What is Zimmer Biomet Holdings Inc.?

ZBH (Zimmer Biomet Holdings Inc.):

Why is Zimmer Biomet Holdings Inc. going down?

ZBH stock is down 10.1% on Apr 28, 2026 17:42

• Zimmer Biomet Holdings Inc. is a medical device company that focuses on designing, manufacturing, and marketing orthopedic reconstructive products. The company operates globally, with a strong presence in the medical technology market.
• Recently, ZBH stock dropped by about 6% due to various factors.
• The departure of the CFO and the company's reaffirmation of its full-year revenue outlook in the Q1 report led to the largest single-day decline in the stock since November.
• Investor sentiment may have been impacted by uncertainty regarding leadership changes and their potential effects on financial performance.
• Investors are closely following Zimmer Biomet's growth and margin strategies, particularly in the medical technology sector, amidst ongoing changes in top leadership roles.

ZBH Price Chart

ZBH Technical Analysis

ZBH News

Investors brace for Yum China earnings amid SSS growth concerns By Investing.com

Investors are awaiting Yum China's first-quarter earnings report, with particular attention to same-store sales growth amidst increasing competition in China. Analysts expect improved financial results year-over-year, but concerns about market shifts and profitability in a crowded quick-service restaurant sector remain. The company's expansion strategy and dividend announcement will also be closely watched.

https://www.investing.com/news/earnings/investors-brace-for-yum-china-earnings-amid-sss-growth-concerns-93CH-4642205

Zimmer Biomet down on CEO exit, unchanged outlook (ZBH:NYSE)

Zimmer Biomet's stock declined approximately 6% after the company announced the departure of its CFO and reaffirmed its full-year revenue outlook with its Q1 report. An earlier version of the article incorrectly stated it was the CEO departing, which was later corrected. This decline could mark its largest single-day drop since November.

https://seekingalpha.com/news/4580692-zimmer-biomet-falls-cfo-exit-unchanged-outlook

Brown & Brown stock hits 52-week low at 63.28 USD

Brown & Brown Inc. (BRO) stock has reached a 52-week low of $63.28, marking a 42% decline over the past year despite the company's 33 consecutive years of dividend increases. This downturn comes as the insurance brokerage firm announces the appointment of Eileen Akerson as chief legal officer and releases its annual Global Impact Report, with analysts maintaining a "Buy" rating and price target of $100.

https://www.investing.com/news/company-news/brown--brown-stock-hits-52week-low-at-6328-usd-93CH-4641720

Tractor Supply Company stock hits 52-week low at 35.47 USD

Tractor Supply Company (TSCO) shares have reached a new 52-week low of $35.47, reflecting a significant decline over the past year. Despite a challenging market and recent analyst downgrades due to weaker-than-expected performance in its Companion Animal segment, InvestingPro analysis indicates the stock may be undervalued. Several firms maintain an Outperform rating, suggesting potential for recovery.

https://www.investing.com/news/company-news/tractor-supply-company-stock-hits-52week-low-at-3547-usd-93CH-4641848

Zimmer Biomet Names Interim CFO as Suketu Upadhyay Departs

Zimmer Biomet has appointed Paul Stellato as interim chief financial officer following the departure of Suketu Upadhyay, who is leaving to pursue another professional opportunity at Incyte. Stellato, previously controller and chief accounting officer, will serve during the search for a permanent successor. The transition comes as Zimmer Biomet continues its growth and margin initiatives in the medical technology market, focusing on digital surgery and robotics.

https://www.citybiz.co/article/837975/zimmer-biomet-names-interim-cfo-as-suketu-upadhyay-departs/

Trending Today

Tilray Inc. ($TLRY) Stock Forecast: Down 5.3% Today

Incyte Corporation ($INCY) Stock Forecast: Up 1.3% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Down 5.0% Today

Credo Technology Group ($CRDO) Stock Forecast: Down 7.3% Today

United Parcel Service Inc. ($UPS) Stock Forecast: Down 4.9% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Down 5.2% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.1% Today

Universal Health Services Inc. ($UHS) Stock Forecast: Down 6.9% Today

Albemarle Corporation ($ALB) Stock Forecast: Down 5.1% Today

Packaging Corporation of America ($PKG) Stock Forecast: Up 3.1% Today

Zimmer Biomet Holdings Inc. Price History

13.00.2026 - ZBH Stock was down 2.3%

• During the third quarter of 2025, Nisa Investment Advisors LLC notably decreased its ownership in Zimmer Biomet Holdings, Inc. by 39.8%, potentially indicating a lack of faith in the company's upcoming performance, which might have contributed to the recent market decline.
• Zimmer Biomet Holdings Inc. demonstrated weaker performance compared to its industry counterparts, potentially due to factors beyond what has been publicly revealed, fostering a pessimistic market mood.
• The departure of Mark Bezjak, a vital executive at Zimmer Biomet Holdings, triggered concerns among shareholders regarding leadership stability and future strategic plans, adversely affecting the stock value.
• Following Mark R. Bezjak's appointment at Dentsply Sirona, where he previously held leadership positions at Zimmer Biomet, investors may have grown uneasy about potential competitive shifts towards a rival firm, leading to the downturn in Zimmer Biomet's stock price.

10.01.2026 - ZBH Stock was up 5.3%

• Strong fourth-quarter financial results from Zimmer Biomet exceeded revenue and earnings predictions, leading to the stock's upward trend.
• Despite the positive results, the company's cautious approach to its 2026 guidance, citing the ever-changing healthcare landscape, initially caused a slight decline in pre-market stock prices.
• The strategic shift towards a direct and specialized sales model in the U.S., as highlighted by the CEO, likely bolstered investor confidence in the company's future growth.
• A newly announced $1.5 billion stock repurchase program also contributed to positive investor sentiment and the stock's upward trajectory.

28.03.2026 - ZBH Stock was down 6.7%

• Following the departure of the CFO, Suketu Upadhyay, despite the positive financial outcomes and upgraded full-year guidance, investor uncertainty emerged, triggering a downward trend in the stock price.
• The market's response to the appointment of an interim CFO and the impending search for a permanent successor is viewed as a potential risk factor to the company's future financial performance.
• The prevailing bearish momentum might also be influenced by profit-taking actions subsequent to the strong earnings disclosure, prompting investors to review the stock's valuation and growth prospects in the medical technology sector.

28.03.2026 - ZBH Stock was down 7.7%

• Experienced a strong bearish movement today.
• The departure of the Chief Financial Officer, Suketu Upadhyay, and the appointment of an interim CFO may have caused uncertainty and investor concern.
• The market reacted negatively to the CFO transition, possibly interpreting it as a potential disruption to Zimmer Biomet's growth and margin initiatives.
• Investors may be monitoring the situation closely for any further developments or announcements regarding the company's financial leadership.

14.00.2026 - ZBH Stock was down 5.2%

• ZBH shares exhibited a significant drop following the company's conservative statements about its future at the J.P. Morgan Healthcare Conference, reflecting concerns among investors about its upcoming performance.
• Despite the recent bearish market movement, evaluations still consider Zimmer Biomet a worthwhile investment opportunity, supported by favorable valuation metrics and financial stability. This indicates that short-term apprehensions may be overshadowing its long-term prospects.
• The decision from Nisa Investment Advisors LLC to sell ZBH shares, alongside other institutional investors increasing their holdings, could have amplified the selling pressure, contributing to the downward trend.
• The recent appointment of Mark R. Bezjak as Group Vice President at Dentsply Sirona, who had a prior role at Zimmer Biomet, might have indirectly influenced the market sentiment towards ZBH, prompting investors to evaluate potential implications on competitiveness and industry dynamics.

07.07.2025 - ZBH Stock was up 7.5%

• ZBH stock saw a strong bullish trend today due to the release of their Q2 earnings and revenue beating expectations, along with an increase in full-year EPS guidance. This positive development suggests promising performance and growth potential for the company.
• Investors reacted positively to ZBH's robust showing in the Hips, Knees, and S.E.T. segments, despite an anticipated decline in year-over-year earnings. The focus appears to be on the overall positive outcomes and updated guidance.
• The market's reaction may also be attributed to ZBH's adept navigation of the competitive medical device industry landscape and its consistent delivery of strong financial results, which has bolstered investor confidence.

04.01.2026 - ZBH Stock was up 2.8%

• ZBH stock experienced a strong bullish movement recently.
• Positive market sentiment was fueled by expectations of increased earnings and higher revenues for the quarter ending December 2025.
• Despite some analyst revisions and a negative Earnings ESP, optimistic growth projections and the company's robust fundamentals likely boosted investor confidence.
• The increase in stake by the National Pension Service and the company's solid reputation as a reliable dividend cornerstone might have positively impacted the stock's performance.

28.03.2026 - ZBH Stock was down 10.1%

• Zimmer Biomet Holdings Inc. is a medical device company that focuses on designing, manufacturing, and marketing orthopedic reconstructive products. The company operates globally, with a strong presence in the medical technology market.
• Recently, ZBH stock dropped by about 6% due to various factors.
• The departure of the CFO and the company's reaffirmation of its full-year revenue outlook in the Q1 report led to the largest single-day decline in the stock since November.
• Investor sentiment may have been impacted by uncertainty regarding leadership changes and their potential effects on financial performance.
• Investors are closely following Zimmer Biomet's growth and margin strategies, particularly in the medical technology sector, amidst ongoing changes in top leadership roles.

14.03.2026 - ZBH Stock was up 5.3%

• The bullish movement in ZBH stock can be attributed to positive analyst coverage and market sentiment surrounding the company's resilience in navigating supply chain challenges in the medtech industry.
• Analysts' cautiously optimistic views, particularly from Leerink Partners initiating coverage with a Market Perform rating and a price target of $101.00, have likely bolstered investor confidence in Zimmer Biomet's long-term growth prospects.
• The company's recent surpassing of Q4 earnings expectations and strategic restructuring, including the launch of new products like the mBôs robot, have also contributed to the positive momentum in its stock price.
• Despite potential near-term growth limitations due to market dynamics, ZBH's strong balance sheet, leadership in robotics, and focus on addressing supply chain disruptions position it favorably for sustained gains in the future.

05.10.2025 - ZBH Stock was down 12.5%

• Weak performance in Latin America and specific EU markets affected the projected organic growth, resulting in a decline in the stock value.
• Despite the positive earnings, the stock has been on a downward trajectory in the past year, potentially contributing to the recent bearish trend.
• An uptick in short interest as a percentage of float suggests a growing bearish outlook among investors, adding to the downward pressure on the stock.
• Market sentiment towards Zimmer Biomet Holdings Inc. appears cautious, with investors closely monitoring its performance in key markets.

05.10.2025 - ZBH Stock was down 10.2%

• The decrease in Zimmer Biomet Holdings Inc.'s stock price today could be attributed to the negative trend in its P/E ratio, indicating potential overvaluation concerns among investors.
• The rise in short interest percentage suggests that more investors are betting against the company, possibly due to concerns about its future performance or market conditions.
• These factors combined may have led to a lack of confidence in Zimmer Biomet Holdings Inc.'s stock, resulting in the bearish movement observed today.

05.10.2025 - ZBH Stock was down 15.5%

• Despite Zimmer Biomet exceeding Q3 earnings forecasts, the stock faced a decline in revenue and a reduced outlook, resulting in an early slide.
• Challenges in Latin America and select EU markets affected the company's projected organic growth, contributing to the stock's downward trend.
• The stock price dropped by 0.84% in the latest market session, marking a significant 9.34% decrease over the past year.
• Zimmer Biomet Holdings Inc.'s short interest as a percentage of float has increased, indicating a rise in bearish sentiment among investors.